Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 mars 2026 14h21 HE | Source: Robbins LLP

POM Class Action: POMDoctor Ltd. Stockholders with Large Losses Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is Investigating Allegations that POMDoctor Ltd. (POM) was the Subject of a Pump-and-Dump Scheme
04 mars 2026 13h40 HE | Source: Robbins LLP

Robbins LLP Urges MREO Stockholders to Contact the Firm for Information About the Class Action Against Mereo BioPharma Group plc

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
17 févr. 2026 14h29 HE | Source: Robbins LLP

Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects
16 févr. 2026 19h42 HE | Source: Robbins LLP

QURE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the uniQure N.V. Class Action

The Allegations: Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Drug.
06 févr. 2026 16h10 HE | Source: Robbins LLP

PMI Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Picard Medical, Inc. Class Action

Robbins LLP is Investigating Allegations that Picard Medical, Inc. (PMI) was the Subject of a Fraudulent Stock Promotion Scheme
14 janv. 2026 14h36 HE | Source: Robbins LLP

ARDT Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Ardent Health, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Ardent Health, Inc. (ARDT) Misled Investors Regarding its Accounts Receivable
29 déc. 2025 19h41 HE | Source: Robbins LLP

MCTA Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Charming Medical, Limited Class Action

Robbins LLP is Investigating Allegations that Charming Medical, Limited (MCTA) Engaged in a Fraudulent Stock Promotion Scheme
29 déc. 2025 19h39 HE | Source: Robbins LLP

Integer Holdings Corporation Stockholders with Losses Should Contact Robbins LLP to Learn About Leading the ITGR Securities Class Action

Robbins LLP is Investigating Allegations that Integer Holdings Corporation (ITGR) Misled Investors Regarding Demand for its Products
22 oct. 2025 20h40 HE | Source: Robbins LLP

JSPR Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Jasper Therapeutics, Inc. Class Action

Jasper’s stock fell 55% after disclosures that it lacked adequate controls over third-party manufacturers, misstating its compliance and operations.
10 oct. 2025 19h24 HE | Source: Robbins LLP

ATYR Investor Notice: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against aTyr Pharma, Inc.

Robbins LLP is Investigating Allegations that aTyr Pharma, Inc. (ATYR) Mislead Investors Regarding the Efficacy of its Drug Candidate

Page suivante